Literature DB >> 24481942

Peripheral T cell lymphoma in Asia.

Sanghui Park1, Young Hyeh Ko.   

Abstract

Peripheral T-cell lymphomas (PTCLs) comprise a heterogeneous group of mature T- and NK-cell neoplasms, the incidence of which is higher in Asian countries than in Western countries. Although its etiology is mainly unknown, several risk factors (such as genetic factors, abnormal immunity, environmental factors, and infectious causes) have been proposed. PTCL are classified based on a combination of several parameters, including morphology, site of presentation, viral status, immunophenotype, and specific genetic alterations. Their classification is ongoing, with the emergence of new entities and refinement of existing entities because of the development of diagnostic markers and new genetic alterations. This review presents epidemiologic data for PTCL in Asia, together with recent progress in the pathology of PTCL compared with the WHO 2008 classification.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24481942     DOI: 10.1007/s12185-014-1520-3

Source DB:  PubMed          Journal:  Int J Hematol        ISSN: 0925-5710            Impact factor:   2.490


  84 in total

1.  Malignant lymphoma in northern Iraq: a retrospective analysis of 270 cases according to the World Health Organization classification.

Authors:  R T Yaqo; M D Hughson; F K Sulayvani; N A Al-Allawi
Journal:  Indian J Cancer       Date:  2011 Oct-Dec       Impact factor: 1.224

2.  Discovery of recurrent t(6;7)(p25.3;q32.3) translocations in ALK-negative anaplastic large cell lymphomas by massively parallel genomic sequencing.

Authors:  Andrew L Feldman; Ahmet Dogan; David I Smith; Mark E Law; Stephen M Ansell; Sarah H Johnson; Julie C Porcher; Nazan Ozsan; Eric D Wieben; Bruce W Eckloff; George Vasmatzis
Journal:  Blood       Date:  2010-10-28       Impact factor: 22.113

3.  Central nervous system involvement in anaplastic large cell lymphoma in childhood: results from a multicentre European and Japanese study.

Authors:  Denise Williams; Tetsuya Mori; Alfred Reiter; Wilhelm Woessman; Angelo Rosolen; Grazyna Wrobel; Jozsef Zsiros; Anne Uyttebroeck; Ildiko Marky; Marie-Cécile Le Deley; Laurence Brugières
Journal:  Pediatr Blood Cancer       Date:  2013-05-29       Impact factor: 3.167

Review 4.  Anaplastic large cell lymphoma, ALK-positive.

Authors:  Andrés J M Ferreri; Silvia Govi; Stefano A Pileri; Kerry J Savage
Journal:  Crit Rev Oncol Hematol       Date:  2012-03-21       Impact factor: 6.312

5.  Pathological and clinical characteristics of 1,248 non-Hodgkin's lymphomas from a regional cancer hospital in Shandong, China.

Authors:  Jie Liu; Bao Song; Tingyong Fan; Chengsuo Huang; Chao Xie; Jing Li; Weixia Zhong; Sheng Li; Jinming Yu
Journal:  Asian Pac J Cancer Prev       Date:  2011

6.  Imbalance of peripheral blood and lymph node T cell subpopulations in angioimmunoblastic lymphadenopathy. Report of three cases.

Authors:  G Pizzolo; M Chilosi; L Fiore-Donati; G Perona
Journal:  Haematologica       Date:  1983 Sep-Oct       Impact factor: 9.941

7.  Activated oncogenic pathways and therapeutic targets in extranodal nasal-type NK/T cell lymphoma revealed by gene expression profiling.

Authors:  Siok-Bian Ng; Viknesvaran Selvarajan; Gaofeng Huang; Jianbiao Zhou; Andrew L Feldman; Mark Law; Yok-Lam Kwong; Norio Shimizu; Yoshitoyo Kagami; Katsuyuki Aozasa; Manuel Salto-Tellez; Wee-Joo Chng
Journal:  J Pathol       Date:  2011-01-05       Impact factor: 7.996

8.  TCR-γ expression in primary cutaneous T-cell lymphomas.

Authors:  Socorro Maria Rodríguez-Pinilla; Pablo L Ortiz-Romero; Verónica Monsalvez; Itziar Eraña Tomás; Manuel Almagro; Amparo Sevilla; Gloria Camacho; María Isabel Longo; Águeda Pulpillo; Julio Alexander Diaz-Pérez; Santiago Montes-Moreno; Yolanda Castro; Begoña Echevarría; Izaskun Trébol; Carlos Gonzalez; Lydia Sánchez; Alberto Puime Otín; Luis Requena; Jose L Rodríguez-Peralto; Lorenzo Cerroni; Miguel Ángel Piris
Journal:  Am J Surg Pathol       Date:  2013-03       Impact factor: 6.394

9.  Non-Hodgkin's lymphoma in southeast Turkey: clinicopathologic features of 490 cases.

Authors:  Abdurrahman Isikdogan; Orhan Ayyildiz; Abdullah Buyukcelik; Adem Arslan; Naci Tiftik; Huseyin Buyukbayram; Ekrem Muftuoglu
Journal:  Ann Hematol       Date:  2003-11-26       Impact factor: 3.673

10.  The spectrum of Epstein-Barr virus-associated lymphoproliferative disease in Korea: incidence of disease entities by age groups.

Authors:  Eun-Yoon Cho; Ki-Hyun Kim; Won-Seog Kim; Keon Hee Yoo; Hong-Hoe Koo; Young-Hyeh Ko
Journal:  J Korean Med Sci       Date:  2008-04       Impact factor: 2.153

View more
  15 in total

1.  Guest editorial: peripheral T-cell lymphomas: progress is not "peripheral", but "central".

Authors:  Masaki Yasukawa
Journal:  Int J Hematol       Date:  2014-02-07       Impact factor: 2.490

Review 2.  T-cell Lymphoma Epidemiology: the Known and Unknown.

Authors:  Anh Phan; Rachel Veldman; Mary Jo Lechowicz
Journal:  Curr Hematol Malig Rep       Date:  2016-12       Impact factor: 3.952

3.  EBV and human cancer.

Authors:  Young-Hyeh Ko
Journal:  Exp Mol Med       Date:  2015-01-23       Impact factor: 8.718

4.  Recombinant human endostatin in combination with CHOP regimen for peripheral T cell lymphoma.

Authors:  Qunling Zhang; Junning Cao; Kai Xue; Xiaojian Liu; Dongmei Ji; Ye Guo; Xiaonan Hong
Journal:  Onco Targets Ther       Date:  2016-12-22       Impact factor: 4.147

5.  Phase I/II study of pralatrexate in Japanese patients with relapsed or refractory peripheral T-cell lymphoma.

Authors:  Dai Maruyama; Hirokazu Nagai; Yoshinobu Maeda; Takahiko Nakane; Tatsu Shimoyama; Tomonori Nakazato; Rika Sakai; Takayuki Ishikawa; Koji Izutsu; Ryuzo Ueda; Kensei Tobinai
Journal:  Cancer Sci       Date:  2017-09-04       Impact factor: 6.716

6.  Identification of cell-type-specific mutations in nodal T-cell lymphomas.

Authors:  T B Nguyen; M Sakata-Yanagimoto; Y Asabe; D Matsubara; J Kano; K Yoshida; Y Shiraishi; K Chiba; H Tanaka; S Miyano; K Izutsu; N Nakamura; K Takeuchi; H Miyoshi; K Ohshima; T Minowa; S Ogawa; M Noguchi; S Chiba
Journal:  Blood Cancer J       Date:  2017-01-06       Impact factor: 11.037

7.  Pralatrexate in Chinese Patients with Relapsed or Refractory Peripheral T-cell Lymphoma: A Single-arm, Multicenter Study.

Authors:  Xiaonan Hong; Yuqin Song; Huiqiang Huang; Bing Bai; Huilai Zhang; Xiaoyan Ke; Yuankai Shi; Jun Zhu; Guodong Lu; Stefan Liebscher; Chunxiao Cai
Journal:  Target Oncol       Date:  2019-04       Impact factor: 4.493

8.  Comparison of CHOP vs CHOPE for treatment of peripheral T-cell lymphoma: a meta-analysis.

Authors:  Shu Deng; Shenyun Lin; Jianping Shen; Yuqing Zeng
Journal:  Onco Targets Ther       Date:  2019-03-28       Impact factor: 4.147

Review 9.  How to Sequence Therapies in Peripheral T Cell Lymphoma.

Authors:  Kitsada Wudhikarn; N Nora Bennani
Journal:  Curr Treat Options Oncol       Date:  2021-07-02

10.  CT findings predict survival of patients with peripheral T cell lymphoma: a preliminary study.

Authors:  Wenbin Yang; Sen Jiang; Jianbang Lin; Yangkang Li
Journal:  Radiol Oncol       Date:  2019-01-19       Impact factor: 2.991

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.